p.153 抽出テキスト

come of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 1998; 28: 446-457. PMID: 9737454 762. 日本循環器学会.2020年JCS ガイドライン フォーカスアップデート版 冠動脈疾患患者における抗血栓療法.https://www.j-circ. or.jp/cms/wp-content/uploads/2020/04/JCS2020_Kimura_ Nakamura.pdf 763. Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005; 257: 399-414. PMID: 15836656 764. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-2674. PMID: 17053008 765. Siracuse JJ, Giles KA, Pomposelli FB, et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg 2012; 55: 1001-1007. PMID: 22301210 766. Aihara H, Soga Y, Mii S, et al. RECANALISE Registry Investigators. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ J 2014; 78: 457-464. PMID: 24292129 767. Jones DW, Goodney PP, Eldrup-Jorgensen J, et al. Vascular Study Group of New England. Active smoking in claudicants undergoing lower extremity bypass predicts decreased graft patency and worse overall survival. J Vasc Surg 2018; 68: 796-806.e1.. PMID: 29523437 768. Kalbaugh CA, Gonzalez NJ, Luckett DJ, et al. The impact of current smoking on outcomes after infrainguinal bypass for claudication. J Vasc Surg 2018; 68: 495-502. PMID: 29506947 769. Soga Y, Yokoi H, Urakawa T, et al. Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease. Circ J 2010; 74: 1689-1695. PMID: 20574137 770. de Vries SO, Donaldson MC, Hunink MG. Contralateral symptoms after unilateral intervention for peripheral occlusive disease. J Vasc Surg 1998; 27: 414-421. PMID: 9546226 771. Miura T, Soga Y, Miyashita Y, et al. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther 2014; 21: 381-388. PMID: 24915585 772. Giannopoulos S, Mustapha J, Gray WA, et al. Three-Year Outcomes From the LIBERTY 360 Study of Endovascular Interventions for Peripheral Artery Disease Stratified by Rutherford Category. J Endovasc Ther 2021; 28: 262-274. PMID: 33016805 773. Baubeta Fridh E, Andersson M, Thuresson M, et al. Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study. Eur J Vasc Endovasc Surg 2017; 54: 480-486. PMID: 28797662 774. Saraidaridis JT, Ergul EA, Clouse WD, et al. The Natural History and Outcomes of Endovascular Therapy for Claudication. Ann Vasc Surg 2017; 44: 34-40. PMID: 28479467 775. Mii S, Guntani A, Kawakubo E, et al. Impact of the Geriatric Nutritional Risk Index on the Long-Term Outcomes of Patients Undergoing Open Bypass for Intermittent Claudication. Circ J 2019; 83: 1349-1355. PMID: 31019140 776. Tsujimura T, Iida O, Ishihara T, et al. The impact of coronary artery disease and left ventricular ejection fraction on the prognosis of patients with peripheral artery disease. Intern Med J 2017; 47: 1313- 1316. PMID: 29105269 777. Soga Y, Mii S, Aihara H, et al. ReCANALISE Investigators. Comparison of clinical outcome after bypass surgery vs. endovascular therapy for infrainguinal artery disease in patients with critical limb ischemia. Circ J 2013; 77: 2102-2109. PMID: 23628918 778. Bisdas T, Borowski M, Stavroulakis K, et al. Endovascular Therapy Versus Bypass Surgery as First-Line Treatment Strategies for Critical Limb Ischemia: Results of the Interim Analysis of the CRITISCH Registry. JACC Cardiovasc Interv 2016; 9: 2557-2565. PMID: 28007205 779. Okazaki J, Matsuda D, Tanaka K, et al. Analysis of wound healing time and wound-free period as outcomes after surgical and endovascular revascularization for critical lower limb ischemia. J Vasc Surg 2018; 67: 817-825. PMID: 29032905 780. Takahara M, Kaneto H, Iida O, et al. The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia. Diabetes Care 2010; 33: 2538-2542. PMID: 20843974 781. Suzuki K, Iida O, Yamauchi Y, et al. Impact of Diabetes Mellitus on Critical Limb Ischemia With Below the Knee Disease: Japan Below-the-Knee Artery Treatment Subanalysis. Angiology 2020; 71: 444-451. PMID: 23966570 782. Hata Y, Iida O, Takahara M, et al. Infrapopliteal Anatomic Severity

and Delayed Wound Healing in Patients With Chronic Limb-Threatening Ischemia in the Era of the Global Limb Anatomic Staging System. J Endovasc Ther 2020; 27: 641-646. PMID: 32571134 783. Hata Y, Iida O, Okamoto S, et al. Additional Risk Stratification Using Local and Systemic Factors for Patients with Critical Limb Ischaemia Undergoing Endovascular Therapy in the WIfI Era. Eur J Vasc Endovasc Surg 2019; 58: 548-555. PMID: 31409542 784. Kobayashi N, Hirano K, Nakano M, et al. Development and validation of a new scoring system to predict wound healing after endovascular therapy in critical limb ischemia with tissue loss. J Endovasc Ther 2015; 22: 48-56. PMID: 25775680 785. Utsunomiya M, Takahara M, Iida O, et al. OLIVE Investigators. Wound Blush Obtainment Is the Most Important Angiographic Endpoint for Wound Healing. JACC Cardiovasc Interv 2017; 10: 188- 194. PMID: 28104214 786. Takahara M, Iida O, Soga Y, et al. Duration from Wound Occurrence to Referral to a Vascular Center in Japanese Patients with Critical Limb Ischemia. Ann Vasc Dis 2020; 13: 56-62. PMID: 32273923 787. Utsunomiya M, Takahara M, Iida O, et al. Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia. J Endovasc Ther 2020; 27: 584-594. PMID: 32431246 788. Iida O, Takahara M, Soga Y, et al. Impact of angiosome-oriented revascularization on clinical outcomes in critical limb ischemia patients without concurrent wound infection and diabetes. J Endovasc Ther 2014; 21: 607-615. PMID: 25290786 789. Kobayashi N, Hirano K, Nakano M, et al. Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy. J Vasc Surg 2015; 61: 951- 959. PMID: 25542618 790. Yamamoto K, Taniguchi R, Hosaka A, et al. Fate of the asymptomatic contralateral limb after initial intervention for ipsilateral critical limb ischemia. Int Angiol 2013; 32: 526-531. PMID: 23903313 791. Faglia E, Clerici G, Mantero M, et al. Incidence of critical limb ischemia and amputation outcome in contralateral limb in diabetic patients hospitalized for unilateral critical limb ischemia during 1999-2003 and followed-up until 2005. Diabetes Res Clin Pract 2007; 77: 445-450. PMID: 17316866 792. Morisaki K, Matsumoto T, Matsubara Y, et al. Prognostic factor of the two-year mortality after revascularization in patients with critical limb ischemia. Vascular 2017; 25: 123-129. PMID: 27206469 793. Morisaki K, Furuyama T, Matsubara Y, et al. Thigh sarcopenia and hypoalbuminemia predict impaired overall survival after infrainguinal revascularization in patients with critical limb ischemia. Vascular 2020; 28: 542-547. PMID: 32295496 794. Takahara M, Iida O, Soga Y, et al. Clinical Impact of Measures for Frailty Severity in Poor-Risk Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia. J Atheroscler Thromb 2022; 29: 221-228. PMID: 33518553 795. Takahara M, Iida O, Soga Y, et al. Heterogeneity of Age and Its Associated Features in Patients with Critical Limb Ischemia. Ann Vasc Dis 2020; 13: 300-307. PMID: 33384734 796. Soga Y, Iida O, Takahara M, et al. Beta-blocker Treatment Does Not Worsen Critical Limb Ischemia in Patients Receiving Endovascular Therapy. J Atheroscler Thromb 2015; 22: 481-489. PMID: 25445890 797. Tomoi Y, Soga Y, Iida O, et al. Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia. Cardiovasc Interv Ther 2013; 28: 374- 382. PMID: 23756936 798. Iida O, Takahara M, Soga Y, et al. SPINACH investigators. The Association of Preoperative Characteristics with Reintervention Risk in Patients Undergoing Revascularization for Chronic Limb-Threatening Ischemia. J Atheroscler Thromb 2021; 28: 52-65. PMID: 32224557 799. Wardlaw JM, Chappell FM, Stevenson M, et al. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess 2006; 10: 1-182. PMID: 16904049 800. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453. PMID: 1852179 801. Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis:

gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003; 229: 340-346.